儿科门诊雾化吸入用药情况分析

Application of Aerosol Inhalation Drugs in the Outpatient Department of Pediatrics

目的规范儿科门诊雾化用药。方法采用回顾性分析法,随机抽取医院儿科门诊2016年10月至2018年9月使用雾化吸入药物的处方3 600份,对雾化药物种类、处方诊断、联合用药和不合理处方进行统计与分析。结果医院儿科门诊雾化吸入药物处方中最常用药物是吸入性糖皮质激素、速效β2受体激动剂和胆碱M受体拮抗剂;雾化处方的主要诊断为支气管炎(62. 89%),其次为上呼吸道感染(18. 03%);雾化联合用药比例为6. 42%,雾化药物治疗不合理率为1. 00%。结论医院儿科门诊雾化吸入药物的使用基本合理,但吸入性糖皮质激素的临床使用率偏高,还需进一步规范,以提高雾化疗效。

Objective To standardize the application of aerosol drugs in the Outpatient Department of Pediatrics. Methods A retrospective analysis method was used to randomly select 3 600 prescriptions of aerosol inhalation drugs from October 2016 to September 2018 in the Outpatient Department of Pediatrics in our hospital. The types of aerosol drugs,prescription diagnosis,combined use of drugs and unreasonable prescriptions were statistically analyzed. Results The most commonly used drugs in the prescriptions of aerosol inhalation drugs in the Outpatient Department of Pediatrics in our hospital were inhaled corticosteroids,fast-acting β2 receptor agonists and choline M receptor antagonists. The main diagnosis of diseases treated with aerosol prescriptions was bronchitis( 62. 89%),followed by upper respiratory tract infection( 18. 03%). The proportion of aerosol combined drug use was 6. 42%,and the irrational rate of aerosol drug treatment was 1. 00%. Conclusion The application of aerosol inhalation drugs in the Outpatient Department of Pediatrics in our hospital is basically reasonable,but the clinical use rate of inhaled corticosteroids is high,and further standardization is needed to improve the efficacy of aerosol therapy.